Cytokines and neuronal channels: A molecular basis for age-related decline of neuronal function?

Experimental Gerontology

Volumn 46, Issue 2-3, 2011, Pages 199-206

  Viviani, Barbara ^a   Boraso, MariaSerena ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Aging; Cytokines; IL 1 ; Ion channel; Neuroinflammation

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GROWTH FACTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

AGING; ALZHEIMER DISEASE; ARTICLE; AUTOCRINE EFFECT; BLOOD BRAIN BARRIER; BRAIN DISEASE; BRAIN FUNCTION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; CYTOKINE PRODUCTION; HUMAN; INFLAMMATION; MEMORY DISORDER; MICROGLIA; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

AGING; ANIMALS; BRAIN; CYTOKINES; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; ION CHANNELS; NEURONS;

EID: 78751704301     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.09.008     Document Type: Article

References (140)

1. Abraham J., Jang S., Godbout J.P., Chen J., Kelley K.W., Dantzer R., Johnson R.W. Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120. Neurobiol. Aging 2008, 29:614-621.
2. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol. Aging 2000, 21:383-421.
3. Alheim K., Bartfai T. The interleukin-1 system: receptors, ligands, and ICE in the brain and their involvement in the fever response. Ann. NY Acad. Sci. 1998, 840:51-58.
4. Allan S.M., Rothwell N.J. Cytochines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
5. Allan S.M., Parker L.C., Collins B., Davies R., Luheshi G.N., Rothwell N.J. Cortical cell death induced by IL-1 is mediated via actions in the hypothalamus of the rat. Proc. Natl Acad. Sci. USA 2000, 97:5580-5585.
6. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
7. Augustine G.J., Charlton M.P., Smith S.J. Calcium action in synaptic transmitter release. Annu. Rev. Neurosci. 1987, 10:633-693.
8. Banks W.A. The blood-brain barrier in psychoneuroimmunology. Neurol. Clin. 2006, 24:413-419.
9. Banks W.A., Farr S.A., La Scola M.E., Morley J.E. Intravenous human interleukin-1alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J. Pharmacol. Exp. Ther. 2001, 299:536-541.
10. Barrientos R.M., Higgins E.A., Biedenkapp J.C., Sprunger D.B., Wright-Hardesty K.J., Watkins L.R., Rudy J.W., Maier S.F. Peripheral infection and aging interact to impair hippocampal memory consolidation. Neurobiol. Aging 2006, 27:723-732.
11. Beattie E.C., Stellwagen D., Morishita W., Bresnahan J.C., Ha B.K., Von Zastrow M., Beattie M.S., Malenka R.C. Control of synaptic strength by glial TNFalpha. Science 2002, 295:2282-2285.
12. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 2005, 25:6734-6744.
13. Biber K., Neumann H., Inoue K., Boddeke H.W. Neuronal 'on' and 'off' signals control microglia. Trends Neurosci. 2007, 30:596-602.
14. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
15. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007, 8:57-69.
16. Boutin H., LeFeuvre R.A., Horai R., Asano M., Iwakura Y., Rothwell N.J. Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci. 2001, 21:5528-5534.
17. Brewer G.J. Neuronal plasticity and stressor toxicity during aging. Exp. Gerontol. 2000, 35:1165-1183.
18. Cacabelos R., Barquero M., Garcia P., Alvarez X.A., Valera de Seijas E. Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find. Exp. Clin. Pharmacol. 1991, 13:455-458.
19. Cady C., Evans M.S., Brewer G.J. Age-related differences in NMDA responses in cultured rat hippocampal neurons. Brain Res. 2001, 921:1-11.
20. Cagnin A., Brooks D.J., Kennedy A.M., Gunn R.N., Myers R., Turkheimer F.E., Jones T., Banati R.B. In-vivo measurement of activated microglia in dementia. Lancet 2001, 358:416-417.
21. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav. Immun. 2008, 22:301-311.
22. Collingridge G.L., Isaac J.T., Wang Y.T. Receptor trafficking and synaptic plasticity. Nat. Rev. Neurosci. 2004, 5:952-962.
23. Combrinck M.I., Perry V.H., Cunningham C. Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 2002, 112:7-11.
24. Cunningham A.J., Murray C.A., O'Neill L.A., Lynch M.A., O'Connor J.J. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci. Lett. 1996, 203:17-20.
25. Cunningham C., Wilcockson D.C., Campion S., Lunnon K., Perry V.H. Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 2005, 25:9275-9284.
26. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-56.
27. Del Rio-Hortega P. Cytology and Cellular Pathology of the Nervous System 1932, Penfeild Wed, New York. P.P. Hocker (Ed.).
28. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
29. Ferguson A.R., Christensen R.N., Gensel J.C., Miller B.A., Sun F., Beattie E.C., Bresnahan J.C., Beatties M.S. Cell death after spinal cord injury is exacerbated by rapid TNF alpha-induced trafficking of GluR2-lacking AMPARs to the plasma membrane. J. Neurosci. 2008, 28:11391-11400.
30. Fogal B., Hewett S.J. Interleukin-1b: a bridge between inflammation and excitotoxicity?. J. Neurochem. 2008, 106:1-23.
31. Franceschi C., Bonafè M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. NY Acad. Sci. 2000, 908:244-254.
32. Franceschi C., Valensin S., Lescai F., Olivieri F., Licastro F., Grimaldi L.M., Monti D., De Benedictis G., Bonafè M. Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype. Aging 2001, 13:163-170.
33. Frank M.G., Barrientos R.M., Biedenkapp J.C., Rudy J.W., Watkins L.R., Maier S.F. mRNA up-regulation of MHC II and pivotal pro-inflammatory genes in normal brain aging. Neurobiol. Aging 2006, 27:717-722.
34. Giri J.G., Lomedico P.T., Mizel S.B. Studies on the synthesis and secretion of interleukin 1. I. A 33, 000 molecular weight precursor for interleukin 1. J. Immunol. 1985, 134(1):343-349.
35. Godbout J.P., Chen J., Abraham J., Richwine A.F., Berg B.M., Kelley K.W., Johnson R.W. Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J. 2005, 19:1329-1331.
36. Godbout J.P., Moreau M., Lestage J., Chen J., Sparkman N.L., O'Condor J., Castanon N., Kelley K.W., Dantzer R., Johnson R.W. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008, 33:2341-2351.
37. Griffin W.S., Mrak R.E. Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukoc. Biol. 2002, 72:233-238.
38. Griffin W.S., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl Acad. Sci. USA 1989, 86:7611-7615.
39. Griffin R., Nally R., Nolan Y., McCartney Y., Linden J., Lynch M.A. The age-related attenuation in long-term potentiation is associated with microglial activation. J. Neurochem. 2006, 99:1263-1272.
40. Grimaldi L.M., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G., Biunno I., De Bellis G., Sorbi S., Mariani C., Canal N., Griffin W.S., Franceschi M. Association of early-onset Alzheimer's disease with an interleukin-1 alpha gene polymorphism. Ann. Neurol. 2000, 47(3):361-365.
41. Hanisch U.K. Microglia as a source and target of cytokines. Glia 2002, 40:140-155.
42. Hanisch U.K., Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 2007, 10:1387-1394.
43. Hayakawa N., Kato H., Araki T. Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector. Mech. Ageing Dev. 2007, 128:311-316.
44. Hein A.M., Stasko M.R., Matousek S.B., Scott-McKean J.J., Maier S.F., Olschowka J.A., Costa A.C., O'Banion M.K. Sustained hippocampal IL-1beta overexpression impairs contextual and spatial memory in transgenic mice. Brain Behav. Immun. 2010, 24:243-253.
45. Hellstrom I.C., Danik M., Luheshi G.N., Williams S. Chronic LPS exposure produces changes in intrinsic membrane properties and a sustained IL-beta-dependent increase in GABAergic inhibition in hippocampal CA1 pyramidal neurons. Hippocampus 2005, 15:656-664.
46. Henry C.J., Huang Y., Wynne A.M., Godbout J.P. Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory and anti-inflammatory IL-10 cytokines 2009.
47. Hermann G.E., Rogers R.C., Bresnahan J.C., Beattie M.S. Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol. Dis. 2001, 8:590-599.
48. Heyen J.R., Ye S., Finck B.N., Johnson R.W. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. Brain Res. Mol. Brain Res. 2000, 77:138-147.
49. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175:4320-4330.
50. Jasek M.C., Griffith W.H. Pharmacological characterization of ionotropic excitatory amino acid receptors in young and aged rat basal forebrain. Neuroscience 1998, 82:1179-1194.
51. Katsuki H., Nakai S., Hirai Y., Akaji K., Kiso Y., Satoh M. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur. J. Pharmacol. 1990, 181:323-326.
52. Kennedy M.B. Regulation of synaptic transmission in the central nervous system: long-term potentiation. Cell 1989, 59:777-787.
53. Korherr C., Hofmeister R., Wesche H., Falk W. A critical role for interleukin-1 receptor accessory protein in interleukin signaling. Eur. J. Immunol. 1997, 27:262-267.
54. Kostyuk P., Pronchuk N., Savchenko A., Verkhratsky A. Calcium currents in aged rat dorsal root ganglion neurones. J. Physiol. 1993, 461:467-483.
55. Krueger J.M., Fang J., Taishi P., Chen Z., Kushikata T., Gardi J. Sleep. A physiological role for IL-1 beta and TNF-alpha. Ann. NY Acad. Sci. 1998, 856:148-159.
56. Lai H.C., Jan L.Y. The distribution and targeting of neuronal voltage-gated ion channels. Nat. Rev. Neurosci. 2006, 7:548-562.
57. Lawrence C.B., Allan S.M., Rothwell N.J. Interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Eur. J. Neurosci. 1998, 10:1188-1195.
58. Leonoudakis D., Zhao P., Beattie E.C. Rapid tumor necrosis factor alpha-induced exocytosis of glutamate receptor 2-lacking AMPA receptors to extrasynaptic plasma membrane potentiates excitotoxicity. J. Neurosci. 2008, 28:2119-2130.
59. Letiembre M., Hao W., Liu Y., Walter S., Mihaljevic I., Rivest S., Hartmann T., Fassbender K. Innate immune receptor expression in normal brain aging. Neuroscience 2007, 146:248-254.
60. Licastro F., Veglia F., Chiappelli M., Grimaldi L.M., Masliah E. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease. Neurobiol. Aging 2004, 25:1017-1022.
61. Liu L., Yang T.M., Liedtke W., Simon S.A. Chronic IL-1beta signaling potentiates voltage-dependent sodium currents in trigeminal nociceptive neurons. J. Neurophysiol. 2006, 95:1478-1490.
62. Liu Y., Wong T.P., Aarts M., Rooyakkers A., Liu L., Lai T.W., Wu D.C., Lu J., Tymianski M., Craig A.M., Wang Y.T. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J. Neurosci. 2007, 27:2846-2857.
63. Liu S., Xu G.Y., Johnson K.M., Echetebu C., Ye Z.S., Hulsebosch C.E., McAdoo D.J. Regulation of interleukin-1 beta by the interleukin-1 receptor antagonist in the glutamate-injured spinal cord: endogenous neuroprotection. Brain Res. 2008, 1231:63-74.
64. Loane D.J., Deighan B.F., Clarke R.M., Griffin R.J., Lynch A.M., Lynch M.A. Interleukin-4 mediates the neuroprotective effects of rosiglitazone in the aged brain. Neurobiol. Aging 2009, 30:920-931.
65. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 2004, 429:883-891.
66. Lukiw W.J. Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem. Res. 2004, 29:1287-1297.
67. Lynch M.A. Age-related neuroinflammatory changes negatively impact on neuronal function. Front. Aging Neurosci. 2010, 1:6. 10.3389/neuro.24.006.2009.
68. Lynch A.M., Lynch M.A. The age-related increase in IL-1 type I receptor in rat hippocampus is coupled with an increase in caspase-3 activation. Eur. J. Neurosci. 2001, 15:1779-1788.
69. (2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. J. Biol. Chem. 2000, 275:4713-4718.
70. Maher F.O., Nolan Y., Lynch M.A. Down-regulation of IL-4-induced signalling in hippocampus contributes to deficits in LTP in aged rat. Neurobiol. Aging 2005, 26:717-728.
71. Maher F.O., Clarke R.M., Kelly A., Nally R.E., Lynch M.A. Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J. Neurochem. 2006, 96:1560-1571.
72. Maier S.F. Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav. Immun. 2003, 17:69-85.
73. Mattson M.P., Magnus T. Ageing and neuronal vulnerability. Nat. Rev. Neurosci. 2006, 7:278-294.
74. Mattson M.P., Dou P., Kater S.B. Outgrowth-regulating actions of glutamate in isolated hippocampal pyramidal neurons. J. Neurosci. 1988, 8:2087-2100.
75. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
76. McGeer P.L., Itagaki S., Tago H., McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 1987, 79:195-200.
77. Medzhitov R., Preston-Hurlburt P., Kopp E., Stadlen A., Chen C., Ghosh S., Janeway C.A. MyD88 is an adaptator protein in the hToll/receptor family signaling pathways. Mol. Cell 1998, 2:253-258.
78. Miller L.G., Galpern W.R., Dunlap K., Dinarello C.A., Turner T.J. Interleukin-1 augments gamma-aminobutyric acidA receptor function in brain. Mol. Pharmacol. 1991, 39:105-108.
79. Milligan E.D., Watkins L.R. Pathological and protective roles of glia in chronic pain. Nat. Rev. Neurosci. 2009, 10:23-36.
80. Mizushima H., Zhou C.J., Dohi K., Horai R., Asano M., Iwakura Y., Hirabayashi T., Arata S., Nakajo S., Takaki A., Ohtaki H., Shioda S. Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1. J. Comp. Neurol. 2002, 448:203-216.
81. Morgan S.C., Taylor D.L., Pocock J.M. Microglia release activators of neuronal proliferation mediated by activation of mitogen-activated protein kinase, phosphatidylinositol-3-kinase/Akt and delta-Notch signalling cascades. J. Neurochem. 2004, 90:89-101.
82. Murray C.A., McGahon B., McBennett S., Lynch M.A. Interleukin-1 beta inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiol. Aging 1997, 18:343-348.
83. Nesic O., Xu G.Y., McAdoo D., High K.W., Hulsebosch C., Perez-Pol R. IL-1 receptor antagonist prevents apoptosis and caspase-3 activation after spinal cord injury. J. Neurotrauma 2001, 18:947-956.
84. Nicoll J.A., Mrak R.E., Graham D.I., Stewart J., Wilcock G., MacGowan S., Esiri M.M., Murray L.S., Dewar D., Love S., Moss T., Griffin W.S. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 2000, 47:365-368.
85. O'Donnell E., Vereker E., Lynch M.A. Age-related impairment in LTP is accompanied by enhanced activity of stress-activated protein kinases: analysis of underlying mechanisms. Eur. J. Neurosci. 2000, 12:345-352.
86. Palmer A.M. The role of the blood-CNS barrier in CNS disorders and their treatment. Neurobiol. Dis. 2010, 37:3-12.
87. Pearson V.L., Rothwell N.J., Toulmond S. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Glia 1999, 25:311-323.
88. Pekny M., Nilsson M. Astrocyte activation and reactive gliosis. Glia 2005, 50:427-434.
89. Penninx B.W., Kritchevsky S.B., Yaffe K., Newman A.B., Simonsick E.M., Rubin S., Ferrucci L., Harris T., Pahor M. Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol. Psychiatry 2003, 54:566-572.
90. Perry V.H., Matyszak M.K., Fearn S. Altered antigen expression of microglia in the aged rodent CNS. Glia 1993, 7:60-67.
91. Perry V.H., Cunningham C., Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 2007, 7:161-167.
92. Plata-Salaman C.R., ffrench-Mullen J.M. Interleukin-1 beta depresses calcium currents in CA1 hippocampal neurons at pathophysiological concentrations. Brain Res. Bull. 1992, 29:221-223.
93. Plata-Salaman C.R., ffrench-Mullen J.M. Interleukin-1 beta inhibits Ca2+ channel currents in hippocampal neurons through protein kinase C. Eur. J. Pharmacol. 1994, 266:1-10.
94. Pousset F., Cremona S., Dantzer R., Kelley K., Parnet P. Interleukin-4 and interleukin-10 regulate IL1-beta induced mouse primary astrocyte activation: a comparative study. Glia 1999, 26:12-21.
95. (2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J. Neurochem. 2001, 78:960-971.
96. Rachal Pugh C., Fleshner M., Watkins L.R., Maier S.F., Rudy J.W. The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci. Biobehav. Rev. 2001, 25:29-41.
97. Rada P., Mark G.P., Vitek M.P., Mangano R.M., Blume A.J., Beer B., Hoebel B.G. Interleukin-1 beta decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res. 1991, 550:287-290.
98. Radons J., Gabler S., Wesche H., Korherr C., Hofmeister R., Falk W. Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling. J. Biol. Chem. 2002, 277:16456-16463.
99. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 1992, 29:243-246.
100. Rogers J., Luber-Narod J., Styren S.D., Civin W.H. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol. Aging 1988, 9:339-349.
101. Ross F.M., Allan S.M., Rothwell N.J., Verkhratsky A. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J. Neuroimmunol. 2003, 144:61-67.
102. Rothwell N.J. Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 1991, 12:430-436.
103. Salter M.W., Kalia L.V. Src kinases: a hub for NMDA receptor regulation. Nat. Rev. Neurosci. 2004, 5:317-328.
104. Saper C.B., Breder C.D. Endogenous pyrogens in the CNS: role in the febrile response. Prog. Brain Res. 1992, 93:419-428. discussion 428-429.
105. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc. Natl Acad. Sci. USA 1998, 95:7778-7783.
106. 2+ current in adult rat ventricular myocytes. Am. J. Physiol. 1997, 272:H2591-H2598.
107. Schroder K., Sweet M.J., Hume D.A. Signal integration between IFNgamma and TLR signalling pathways in macrophages. Immunobiology 2006, 211:511-524.
108. Sheffield L.G., Berman N.E. Microglial expression of MHC class II increases in normal aging of nonhuman primates. Neurobiol. Aging 1998, 19:47-55.
109. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., et al. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl Acad. Sci. USA 1993, 90:6155-6159.
110. Sparkman N.L., Johnson R.W. Neuroinflammation associated with aging sensitizes the brain to the effect of infection or stress. Neuroimmunomodulation 2008, 15:323-330.
111. Spulber S., Schultzberg M. Connection between inflammatory processes and transmittor function - modulatory effects of interleukin-1. Prog. Neurobiol. 2010, 90:256-262.
112. Stellwagen D., Beattie E.C., Seo J.Y., Malenka R.C. Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J. Neurosci. 2005, 25:3219-3228.
113. Streit W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 2002, 40:133-139.
114. Streit W.J., Sammons N.W., Kuhns A.J., Sparks D.L. Dystrophic microglia in the aging human brain. Glia 2004, 45:208-212.
115. Terao A., Apte-Deshpande A., Dousman L., Morairty S., Eynon B.P., Kilduff T.S., Freund Y.R. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 2002, 132:99-112.
116. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J., et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 1992, 356:768-774.
117. Toescu E.C., Verkhratsky A. Parameters of calcium homeostasis in normal neuronal ageing. J. Anat. 2000, 197:563-569.
118. Trompet S., de Craen A.J., Slagboom P., Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Ford I., Gaw A., Macfarlane P.W., Packard C.J., Scott D.J., Jukema J.W., Westendorp R.G. Genetic variation in the interleukin-1 beta-converting enzyme associates with cognitive function. The PROSPER study. Brain 2008, 131:1069-1077. PROSPER Group.
119. Ureshino R.P., Bertoncini C.R., Fernandes M.J., Abdalla F.M., Porto C.S., Hsu Y.T., Lopes G.S., Smaili S.S. Alterations in calcium signaling and a decrease in Bcl-2 expression: possible correlation with apoptosis in aged striatum. J. Neurosci. Res. 2010, 88:438-447.
120. Vasto S., Candore G., Balistreri C.R., Caruso M., Colonna-Romano G., Grimaldi M.P., Listi F., Nuzzo D., Lio D., Caruso C. Inflammatory networks in ageing, age-related diseases and longevity. Mech. Ageing Dev. 2007, 128:83-91.
121. Vaughan D.W., Peters A. Neuroglial cells in the cerebral cortex of rats from young adulthood to old age: an electron microscope study. J. Neurocytol. 1974, 3:405-429.
122. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1 beta immunoreactivity and microglia are enhanced in the rat hippocamopus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19:5054-5065.
123. Vilcek J. The cytokines: an overview. The Cytokine Handbook 1998, 1-20. Academic Press, San Diego. A. Thompson (Ed.).
124. Villa P., Bigini P., Mennini T., Agnello D., Laragione T., Cagnotto A., Viviani B., Marinovich M., Cerami M., Coleman T.R., Brines M., Ghezzi P. Erythropoietin selectively attenuates cytokine production and inflammation in cerebral ischemia by targeting neuronal apoptosis. J. Exp. Med. 2003, 198:971-975.
125. Viviani B., Corsini E., Galli C.L., Padovani A., Ciusani E., Marinovich M. Dying neural cells activate glia through the release of a protease product. Glia 2000, 32:84-90.
126. Viviani B., Bartesaghi S., Gardoni F., Vezzani A., Behrens M.M., Bartfai T., Binaglia M., Corsini E., Di Luca M., Galli C.L., Marinovich M. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003, 23:8692-8700.
127. Viviani B., Bartesaghi S., Corsini E., Galli C.L., Marinovich M. Cytokines role in neurodegenerative events. Toxicol. Lett. 2004, 149:85-89.
128. Viviani B., Gardoni F., Bartesaghi S., Corsini E., Facchi A., Galli C.L., Di Luca M., Marinovich M. IL-1beta released by gp120 drives neuronal death through tyrosine phosphorilation and trafficking of NMDA receptors. J. Biol. Chem. 2006, 281:30212-30222.
129. Viviani B., Gardoni F., Marinovich M. Cytokines and neuronal ion channels in health and disease. Int. Rev. Neurobiol. 2007, 82:247-263.
130. Wahner A.D., Sinsheimer J.S., Bronstein J.M., Ritz B. Inflammatory cytokine gene polymorphisms and increased risk of Parkinson disease. Arch. Neurol. 2007, 64:836-840.
131. Wang S., Cheng Q., Malik S., Yang J. Interleukin-1beta inhibits gamma-aminobutyric acid type A (GABA(A)) receptor current in cultured hippocampal neurons. J. Pharmacol. Exp. Ther. 2000, 292:497-504.
132. Weindruch R., Kayo T., Lee C.K., Prolla T.A. Gene expression profiling of aging using DNA microarray. Mech. Aging Dev. 2002, 123:177-193.
133. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7:837-847.
134. West A.E., Chen W.G., Dalva M.B., Dolmetsch R.E., Kornhauser J.M., Shaywitz A.J., Takasu M.A., Tao X., Greenberg M.E. Calcium regulation of neuronal gene expression. Proc. Natl Acad. Sci. USA 2001, 98:11024-11031.
135. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response?. Nat. Med. 2006, 12:1005-1015.
136. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995, 26:676-680. discussion 681.
137. Yang S., Liu Z.W., Wen L., Qiao H.F., Zhou W.X., Zhang Y.X. Interleukin-1beta enhances NMDA receptor-mediated current but inhibits excitatory synaptic transmission. Brain Res. 2005, 1034:172-179.
138. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 1999, 93:139-148.
139. Ye S.M., Johnson R.W. Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappa B. J. Neuroimmunol. 2001, 117:87-96.
140. Ye S.M., Johnson R.W. An age-related decline in interleukin-10 may contribute to the increased expression of IL-6 in brain of aged mice. Neuroimmunomodulation 2001, 9:183-192.